These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 14152369

  • 41. [Treatment of the ascites and edema of cirrhotics by spironolactone].
    MINICONI P, BOURREILLE J, SUDUCA P, CARAYON P, LAVOCAT G, ISSAD H.
    Alger Medicale; 1962 Jan; 66():1-98. PubMed ID: 14474319
    [No Abstract] [Full Text] [Related]

  • 42. [THE WATER-ELECTROLYTE STATE IN EDEMA CAUSED BY CONGESTIVE CARDIO-CIRCULATORY INSUFFICIENCY. PHYSIOPATHOGENETIC CONSIDERATIONS AND THERAPEUTIC TRENDS].
    POLIMENI R, MARCHESE G.
    Rass Clin Ter; 1964 Jan; 63():13-44. PubMed ID: 14127189
    [No Abstract] [Full Text] [Related]

  • 43. Aldosterone and volume management in hypertensive heart disease.
    Sica DA.
    Semin Nephrol; 2014 May; 34(3):323-32. PubMed ID: 25016402
    [Abstract] [Full Text] [Related]

  • 44. [Spirolactone treatment of liver cirrhosis with edema and ascites].
    OFSTAD J, SIGSTAD H.
    Nord Med; 1962 Jan 04; 67():21-4. PubMed ID: 14481210
    [No Abstract] [Full Text] [Related]

  • 45. [Treatment of cirrhotic ascites by an inhibitor of aldosterone synthesis].
    LEBACQ E.
    Acta Gastroenterol Belg; 1962 Jan 04; 25():709-17. PubMed ID: 13928870
    [No Abstract] [Full Text] [Related]

  • 46. [ON THE TREATMENT OF THERAPY-RESISTANT RETENTION OF FLUIDS WITH SPIROLACTONE].
    DITTRICH H, SEIFERT E.
    Wien Med Wochenschr; 1964 Jan 18; 114():59-61. PubMed ID: 14127235
    [No Abstract] [Full Text] [Related]

  • 47. [Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
    LEVRAT M, BRETTE R, FRANCOIS B, TISSOT A, MESTRALLET G.
    Lyon Med; 1961 May 14; 93():1115-23. PubMed ID: 13761576
    [No Abstract] [Full Text] [Related]

  • 48. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
    Bernardi M, Servadei D, Trevisani F, Rusticali AG, Gasbarrini G.
    Digestion; 1985 May 14; 31(4):189-93. PubMed ID: 4007290
    [Abstract] [Full Text] [Related]

  • 49. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP, MARCHAL C, ANTOINE, SAPELIER P, KIFFER B.
    Rev Med Nancy; 1961 May 14; 86():801-20. PubMed ID: 13901929
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A.
    Minerva Med; 1962 Jun 23; 53():1990-4. PubMed ID: 13871015
    [No Abstract] [Full Text] [Related]

  • 52. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CARDIAC EDEMA].
    KONONIACHENKO VA, GERASIMOVA EN.
    Kardiologiia; 1964 Jun 23; 4():76-86. PubMed ID: 14184139
    [No Abstract] [Full Text] [Related]

  • 53. [Cirrhotic edemas and spironolactone].
    ALBAHARY C, POMMEY B.
    Concours Med; 1962 Mar 24; 84():1759-66. PubMed ID: 13860028
    [No Abstract] [Full Text] [Related]

  • 54. [Effect of SC 9420, mercurial diuretic and hydrochlorothiazide on electrolyte excretion in liver cirrhosis].
    VELASCO M, KATZ R, KATZ E, GARCIA H, GAZMURI R.
    Rev Med Chil; 1959 Dec 24; 87():946-51. PubMed ID: 13841591
    [No Abstract] [Full Text] [Related]

  • 55. [THE SIGNIFICANCE OF DYSREGULATION CAUSED BY DIURETICS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS].
    BRUNNER E.
    Wien Klin Wochenschr; 1963 Sep 20; 75():674-7. PubMed ID: 14059193
    [No Abstract] [Full Text] [Related]

  • 56. Significance of aldosterone antagonism in the treatment of edema and ascites.
    GANTT CL, ECKLUND RE.
    Am J Med; 1962 Oct 20; 33():490-500. PubMed ID: 13946423
    [No Abstract] [Full Text] [Related]

  • 57. DIURETIC THERAPY: A REVIEW.
    IRVINE RO.
    N Z Med J; 1963 Dec 20; 62():581-9. PubMed ID: 14101075
    [No Abstract] [Full Text] [Related]

  • 58. [OUR EXPERIENCE IN THE TREATMENT OF PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS WITH ALDOSTERONE INHIBITORS].
    KNEZEVIC S, HAHN A.
    Lijec Vjesn; 1963 Oct 20; 85():1085-93. PubMed ID: 14097613
    [No Abstract] [Full Text] [Related]

  • 59. The resurrection of spironolactone on its golden anniversary.
    Futterman LG, Lemberg L.
    Am J Crit Care; 2004 Mar 20; 13(2):162-5. PubMed ID: 15043244
    [Abstract] [Full Text] [Related]

  • 60. [ALDOSTERONE INHIBITORS IN THE TREATMENT OF EDEMAS].
    JACONO A, BUONINCONTI R, VITALE P.
    Clin Ter; 1964 Nov 15; 31():195-208. PubMed ID: 14235386
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.